The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


WARFARIN TEVA

10 Milligram Tablets

Sun Pharmaceutical Industries Europe B.V.PA2050/001/009

Main Information

Trade NameWARFARIN TEVA
Active SubstancesWARFARIN SODIUM CLATHRATE
Strength10 Milligram
Dosage FormTablets
Licence HolderSun Pharmaceutical Industries Europe B.V.
Licence NumberPA2050/001/009

Group Information

ATC CodeB01AA03 warfarin

Status

Authorised/WithdrawnAuthorised
Licence Issued26/10/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot Marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back